Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
newsdepo.com
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgradePharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade Read more